Specialist learning creates risk when it travels back as fragments: a slide without its setting, a product claim without its conditions or a protocol idea without the governance that made it safe.
The BOPA Oncology Pharmacy Conference 2027 gives pharmacy leaders three days to develop practice and connect with oncology-pharmacy colleagues. The return on that time depends on the brief taken to Harrogate: which competence needs to grow, which service decision needs evidence and who will translate learning into the local system.
When and where is the BOPA Conference 2027?
BOPA confirms its 30th annual conference for 1–3 October 2027 at Harrogate Convention Centre. The organiser says the event will support practice development, oncology research discussion and professional networking; the detailed programme, registration and other arrangements are still to follow.
- Write one specialist-practice question before the final programme is released.
- Match the delegate to the competence or service gap, not simply to seniority.
- Bring learning home through governance, supervised practice and a measured implementation decision.
Confirmed BOPA Oncology Pharmacy Conference 2027 details
The official BOPA Conference 2027 page confirms that the 30th annual conference will run from Friday 1 to Sunday 3 October 2027 at Harrogate Convention Centre. BOPA describes the event as a place to advance practice, hear oncology research, ask questions and connect with oncology-pharmacy practitioners from across the UK.
The organiser currently says more information will follow. It has not yet published the complete programme, speakers, registration terms, delegate prices, abstract process or sponsor and exhibitor details on the 2027 page. Do not copy a previous BOPA agenda into a 2027 business case or treat earlier speakers, topics and commercial sessions as confirmed.
Use the live organiser page for the final decision. A three-day specialist conference has a material time and travel cost even before ticket and accommodation details are known. The pharmacy’s case for attendance should therefore depend on a defined capability or service question, not on assumed content.
Who is the BOPA Conference 2027 for?
The official page is written for people with a professional interest in oncology pharmacy. It is likely to be most relevant to pharmacists, pharmacy technicians, service leaders, educators, researchers and managers working in or alongside oncology services. Every prospective delegate should check BOPA’s final eligibility and registration route rather than assuming that interest alone is enough.
For a pharmacy leader, the event should answer a question that ordinary internal learning cannot resolve as effectively. That may involve specialist competence, workforce development, service design, evidence, digital support, cross-sector pathways or the implementation burden around a change. It should not be treated as a shortcut into specialist work beyond the person’s role or scope.
A community or online-pharmacy owner should be especially disciplined about fit. Oncology-pharmacy practice is specialist and often sits within hospital or integrated pathways. A useful conference conversation may improve referral awareness, workforce understanding or collaboration without authorising the pharmacy to add a new clinical activity.
Build a pharmacy-leader brief before booking
Start with the decision, not the timetable. “Learn about oncology” is not a conference brief. Name the setting, people, current gap and the action that might follow. A specialist pharmacist may need to compare approaches to competence. A service lead may need better evidence about workload or patient flow. A manager may need to understand a workforce or technology dependency.
A useful one-page brief should include:
- The current service or role and the boundary around it.
- The observed problem, supported by evidence rather than assumption.
- The people affected, including colleagues and partner organisations.
- The knowledge, skill, process or system that may need to change.
- The governance, data, workforce and financial constraints.
- The decision expected after the conference and who owns it.
Use the pharmacy clinical governance guide to map responsibility, competence, controlled procedures, incidents and review. The pharmacy staff training guide helps separate attendance from demonstrated competence in a real task.
| Leadership question | Conference evidence to seek | Return-home gate |
|---|---|---|
| Which competence needs to develop? | Defined capability, supervision model, assessment method and setting | Named supervisor, scope, evidence and review |
| Which service problem needs evidence? | Baseline, population, process, outcomes, workload and limitations | Comparable local data and governance classification |
| Could a technology support the work? | Real workflow, exception, failure, integration, security and support | Formal due diligence and acceptance criteria |
| Would collaboration improve the pathway? | Roles, information flow, referral boundary, escalation and ownership | Partner agreement and a controlled local test |
Choose programme content carefully
When BOPA publishes the final programme, score sessions against the brief. Specialist interest is not enough. Choose content that can clarify the current problem, challenge an assumption or improve implementation. Leave space to compare what was heard rather than moving from session to session without synthesis.
Ask what kind of evidence supports a presentation. Research, audit, quality improvement, service evaluation, expert consensus and local experience answer different questions. Record the setting, population, comparison, limitations and relevance to the delegate’s own organisation. A memorable conclusion should not be detached from the method that produced it.
Clinical content must remain inside the delegate’s professional role and local arrangements. A conference session is not patient-specific advice, a prescribing instruction or approval to change practice. New knowledge may require further reading, formal training, supervised practice, competence assessment and local approval before it affects care.
The GPhC’s scope-of-practice statement connects professional development with working within competence and says organisations should support pharmacy professionals to understand, document and work within their scope. Use the current official document and employer arrangements when planning any change.
Separate education from supplier claims
The 2027 sponsor and exhibitor details are not yet published. If commercial organisations are present, distinguish independent programme content from sponsored sessions, exhibition conversations and product demonstrations. Record which is which in the delegate notes.
Ask a supplier to show the workflow that matters to the brief, including an ordinary case, an exception and a failure. Request the evidence behind time, safety, capacity or cost claims. Capture the denominator, baseline, period, setting, exclusions and implementation conditions. A confident demonstration does not prove local fit.
Do not carry patient-identifiable information into a conference conversation or enter it into an unfamiliar tool. For digital products, ask about identity, access, logging, data flows, hosting, subprocessors, support access, incident response, export and deletion. Use our pharmacy cybersecurity guide for an owner-level due-diligence structure.
Set authority in advance. A delegate may collect information, request a formal demonstration or introduce colleagues. They should not accept a trial, disclose sensitive details or sign an order unless the organisation’s procurement, information-governance, clinical-governance and contract routes have been followed.
Transfer learning into safe practice
Book a structured handover within two working days. Ask the delegate to explain the original problem, evidence heard, limitation, proposed implication and what still needs verification. A list of favourite sessions is not a handover.
Place each proposed change into one of four routes:
- Learn: further reading or discussion is needed before any local action.
- Develop: a colleague needs formal training, supervision or competence evidence.
- Test: a bounded service, workflow or data-quality pilot can answer a defined question.
- Decline: the idea falls outside scope, lacks evidence or does not fit the organisation.
For a test, define who is responsible, which people and systems are affected, the baseline, measure, balancing risk, review date and stop conditions. Update controlled documents and training only through the organisation’s approved process. Do not distribute a conference slide as a local protocol.
Keep partner boundaries explicit. Oncology pathways may cross hospital, primary-care, community, homecare and specialist-service settings. A good conversation can identify a hand-off problem, but any new information flow, referral route or shared responsibility needs agreement from the organisations that own it.
Review the result after 30 days
At day 30, review the decision rather than counting notes or CPD hours. Did the pharmacy clarify a competence requirement, improve an evidence definition, begin a controlled test, strengthen a partner conversation or decide not to proceed? What remains uncertain?
If a learning action is under way, inspect evidence from practice. That may include supervised observation, competence assessment, audit, escalation quality, staff experience or service data. Completion alone does not prove that a colleague can perform a specialist task safely in the relevant setting.
Store the conference brief, source links, handover and action record where the team can find the current version. Our pharmacy intranet guide explains how ownership, review dates and controlled access keep knowledge useful after the delegate returns.
Pharmacy Mentor helps pharmacy leaders connect services, teams, digital systems and evidence into a coherent operating model. Explore our pharmacy growth and digital services, or start a conversation about translating one specialist-service decision into a controlled plan.
Frequently asked questions
When is the BOPA Conference 2027?
BOPA schedules its 30th annual conference for Friday 1 to Sunday 3 October 2027. Confirm the final timetable on the organiser’s live page.
Where is the BOPA Oncology Pharmacy Conference 2027?
The official BOPA page lists Harrogate Convention Centre as the venue.
Who is the BOPA Conference for?
BOPA describes the event for people who want to advance oncology-pharmacy practice, hear research and connect with practitioners. Check the final registration and eligibility terms for each delegate’s role.
Has BOPA published the full 2027 programme?
No. The official 2027 page confirms the dates and venue but says more information will follow. Do not treat an earlier agenda or speaker list as the 2027 programme.
Saam Ali
Founder & CEO, Pharmacy Mentor · MRPharmSSaam Ali is a pharmacist, digital strategist and the founder of Pharmacy Mentor. He has worked across community pharmacy, healthcare marketing and digital product development since 2012, helping independent pharmacies build modern online services and reach more patients.